Towards 3D bioprinted liver tissue constructs: NEOLIVER

On January 21 – 22, 2025, NEOLIVER consortium which develops Automated Generation of Dense, Functional and Perfusable Bioprinted Liver Constructs for Transplantation has met to kick off the project.



After an initial welcome by project coordinator Assoc. Prof. Bart Spee of University of Utrecht, partners listened to a keynote by a patient representative which stressed the urgency of moving research towards clinical use.



In the initial block, a presentation was delivered also by Dr. Mirko Lo Cicero, Project Officer from HaDEA, stressing the key grant management issues.

While partners have reviewed plan for all work packages active in the first year, the focus was put on definition of construct requirements and vascularization approach. Useful inputs were provided by attending EAB members:

• Prof. Dr Paolo Martins, Transplantation surgeon, Oklahoma Health Science Centre
• Jose Willemse, Executive Director, Dutch Liver Patients Association
• Dr. Dirk Groenewegen, Managing Director, Cells4Therapy
  

NEOLIVER is built upon excellent results of ORGANTRANS EU-funded project, which developed the key technologies and concepts, and which successfully transplanted small liver constructs into mice.

NEOLIVER pushes the boundaries of tissue engineering further by automating the bioprinting process and producing a larger functional tissue.

NEOLIVER social media: LinkedIn.